Search Results - "Oellerich, M"

Refine Results
  1. 1
  2. 2

    What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA by Danesi, R., Lo, Y.M.D., Oellerich, M., Beck, J., Galbiati, S., Re, M. Del, Lianidou, E., Neumaier, M., van Schaik, R.H.N.

    Published in Clinica chimica acta (01-09-2021)
    “…•Preanalytical variables influence the quality and quantity of isolated cfDNA.•This paper compares preanalytical aspects published for cfDNA analysis.•Blood…”
    Get full text
    Journal Article
  3. 3

    Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation by Beck, J, Oellerich, M, Schulz, U, Schauerte, V, Reinhard, L, Fuchs, U, Knabbe, C, Zittermann, A, Olbricht, C, Gummert, J.F, Shipkova, M, Birschmann, I, Wieland, E, Schütz, E

    Published in Transplantation proceedings (01-10-2015)
    “…Abstract Background In solid organ transplantation, sensitive real-time biomarkers to assess the graft health are desirable to enable early intervention, for…”
    Get full text
    Journal Article
  4. 4

    Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches by Prémaud, A., Weber, L.T., Tönshoff, B., Armstrong, V.W., Oellerich, M., Urien, S., Marquet, P., Rousseau, A.

    Published in Pharmacological research (01-03-2011)
    “…Mycophenolic acid (MPA) is an immunosuppressive drug widely used in the prevention of acute rejection in pediatric renal transplant recipients and is…”
    Get full text
    Journal Article
  5. 5

    CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity by Brandhorst, G., Weigand, S., Eberle, C., Raddatz, D., Karaus, M., Oellerich, M., Walson, P.D.

    Published in Clinica chimica acta (05-06-2013)
    “…Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBDs) which are characterized by dysfunctional regulation of the immune…”
    Get full text
    Journal Article
  6. 6

    Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients by Naesens, Maarten, Kuypers, Dirk R. J., Streit, Frank, Armstrong, Victor W., Oellerich, Michael, Verbeke, Kristin, Vanrenterghem, Yves

    Published in Clinical pharmacology and therapeutics (01-11-2006)
    “…Background Exposure to mycophenolic acid (MPA) and its main metabolites (MPA 7‐O‐glucuronide [MPAG] and MPA acyl‐glucuronide [AcMPAG]) is characterized by a…”
    Get full text
    Journal Article
  7. 7

    Acyl glucuronide drug metabolites: Toxicological and analytical implications by SHIPKOVA, Maria, ARMSTRONG, Victor William, OELLERICH, Michael, WIELAND, Eberhard

    Published in Therapeutic drug monitoring (01-02-2003)
    “…Although glucuronidation is generally considered a detoxification route of drug metabolism, the chemical reactivity of acyl glucuronides has been linked with…”
    Get full text
    Journal Article
  8. 8

    Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes by Shipkova, M, Strassburg, C P, Braun, F, Streit, F, Gröne, H‐J, Armstrong, V W, Tukey, R H, Oellerich, M, Wieland, E

    Published in British journal of pharmacology (01-03-2001)
    “…Mycophenolic acid (MPA) is primarily metabolized to a phenolic glucuronide (MPAG) as well as to two further minor metabolites: an acyl glucuronide (AcMPAG) and…”
    Get full text
    Journal Article
  9. 9

    Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid by Rother, A., Glander, P., Vitt, E., Czock, D., von Ahsen, N., Armstrong, V. W., Oellerich, M., Budde, K., Feneberg, R., Tönshoff, B., Weber, L. T.

    Published in European journal of clinical pharmacology (01-06-2012)
    “…Purpose Since many drug targets and metabolizing enzymes are developmentally regulated, we investigated a potential comparable regulation of inosine…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney by Wolff, Natascha A., Burckhardt, Birgitta C., Burckhardt, Gerhard, Oellerich, Michael, Armstrong, Victor W.

    Published in Nephrology, dialysis, transplantation (01-09-2007)
    “…Background. Mycophenolic acid (MPA), the active moiety of the prodrug mycophenolate mofetil, is widely used in immunosuppressive regimens after kidney, liver…”
    Get full text
    Journal Article
  13. 13

    Genotyping of Eight Thiopurine Methyltransferase Mutations: Three-Color Multiplexing, "Two-Color/Shared" Anchor, and Fluorescence-quenching Hybridization Probe Assays Based on Thermodynamic Nearest-Neighbor Probe Design by Schutz, Ekkehard, von Ahsen, Nicolas, Oellerich, Michael

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2000)
    “…The inherited deficiency of thiopurine methyltransferase (TPMT) leads to severe myelosuppression in homozygous patients treated with thiopurine derivatives…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus by Schultze, F. C., Petrova, D. T., Oellerich, M., Armstrong, V. W., Asif, A. R.

    Published in Cell proliferation (01-08-2010)
    “…Objectives:  The present study was designed to investigate early proteome and phosphoproteome changes during inhibition of lymphocyte proliferation induced by…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Prenatal dexamethasone exposure in the common marmoset monkey enhances gene expression of antioxidant enzymes in the aorta of adult offspring by Atanasova, S, Wieland, E, Schlumbohm, C, Korecka, M, Shaw, L, von Ahsen, N, Fuchs, E, Oellerich, M, Armstrong, V

    Published in Stress (Amsterdam, Netherlands) (01-01-2009)
    “…Human epidemiological studies have indicated that low birth weight associated with an adverse intrauterine environment is related to a greater incidence of…”
    Get more information
    Journal Article
  18. 18

    Effect of the Antioxidant Idebenone on Adverse Events Under Mycophenolate Mofetil Therapy in a Rat Model by HELLER, Tanja, GEIDE, Anna, BONITZ, Ulrike, WEGNER, Ulrike, GRÖNE, Hermann-Josef, ARMSTRONG, Victor W, OELLERICH, Michael

    Published in Transplantation (15-03-2008)
    “…Diarrhea and anemia are side effects of mycophenolic acid (MPA), but underlying mechanisms are not fully understood. Gene expression of major-alpha-hemoglobin…”
    Get full text
    Journal Article
  19. 19

    Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: a microdialysis study by Kenkel, Jeffrey M, Lipschitz, Avron H, Shepherd, Greene, Armstrong, Victor W, Streit, Frank, Oellerich, Michael, Luby, Maureen, Rohrich, Rod J, Brown, Spencer A

    Published in Plastic and reconstructive surgery (1963) (01-08-2004)
    “…High doses of lidocaine are administered to patients undergoing liposuction. Monoethylglycinexylidide, the active metabolite of lidocaine, is 80 to 90 percent…”
    Get full text
    Journal Article
  20. 20

    Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection by Lorf, T, Schnitzbauer, A A, Schaefers, S K H, Scherer, M N, Schlitt, H J, Oellerich, M, Becker, H, Obed, A

    Published in Hepato-gastroenterology (01-03-2008)
    “…The critical issue before major hepatic resection is to evaluate and detect patients with a potentially increased risk of hepatic failure. In this study the…”
    Get more information
    Journal Article